Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency.
about
Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiencyCCDC22 deficiency in humans blunts activation of proinflammatory NF-κB signalingPrimary immunodeficiencies of pattern recognition receptorsMendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunityUbiquitin in the immune systemMucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapyThe TLR and IL-1 signalling network at a glanceMendelian genetics of human susceptibility to fungal infectionAntimicrobial Proteins and Peptides in Early Life: Ontogeny and Translational OpportunitiesThe immunology of influenza virus-associated bacterial pneumoniaNeutrophils: Between host defence, immune modulation, and tissue injuryMyD88: a central player in innate immune signalingSTAT2 deficiency and susceptibility to viral illness in humansSulphonylurea usage in melioidosis is associated with severe disease and suppressed immune responseDectin-1 Controls TLR9 Trafficking to Phagosomes Containing β-1,3 GlucanTNF and IL-1 exhibit distinct ubiquitin requirements for inducing NEMO-IKK supramolecular structuresStructural dynamic analysis of apo and ATP-bound IRAK4 kinaseIRAK4 Deficiency in a Patient with Recurrent Pneumococcal Infections: Case Report and Review of the Literature.Comparative genomics RNAi screen identifies Eftud2 as a novel regulator of innate immunity.B cell TLRs and induction of immunoglobulin class-switch DNA recombination.Primary immunodeficiencies underlying fungal infectionsInvasive pneumococcal disease in children can reveal a primary immunodeficiency.Cytokine production assays reveal discriminatory immune defects in adults with recurrent infections and noninfectious inflammation.TLR-mediated inflammatory responses to Streptococcus pneumoniae are highly dependent on surface expression of bacterial lipoproteinsInteraction of Streptococcus agalactiae and Cellular Innate Immunity in Colonization and DiseaseInnate immunity networks during infection with Borrelia burgdorferi.DNA polymerase-α regulates the activation of type I interferons through cytosolic RNA:DNA synthesisIRAK-4 and MyD88 deficiencies impair IgM responses against T-independent bacterial antigensA narrow repertoire of transcriptional modules responsive to pyogenic bacteria is impaired in patients carrying loss-of-function mutations in MYD88 or IRAK4Skin fibroblasts from individuals with Chediak-Higashi Syndrome (CHS) exhibit hyposensitive immunogenic response.Defective lymphoid organogenesis underlies the immune deficiency caused by a heterozygous S32I mutation in IκBα.Recurrent invasive pneumococcal disease in children: underlying clinical conditions, and immunological and microbiological characteristics.Rare variants in MYD88, IRAK4 and IKBKG and susceptibility to invasive pneumococcal disease: a population-based case-control studyInherited and acquired immunodeficiencies underlying tuberculosis in childhood.Immunodeficiency among children with recurrent invasive pneumococcal disease.Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia.Interleukin-1 (IL-1) signaling in intestinal stromal cells controls KC/ CXCL1 secretion, which correlates with recruitment of IL-22- secreting neutrophils at early stages of Citrobacter rodentium infection.Sensing of interleukin-1 cytokines during Streptococcus pneumoniae colonization contributes to macrophage recruitment and bacterial clearance.Rapid diagnosis of Propionibacterium acnes infection in patient with hyperpyrexia after hematopoietic stem cell transplantation by next-generation sequencing: a case report.Osteoprotegerin Regulates Pancreatic β-Cell Homeostasis upon Microbial Invasion
P2860
Q24301912-B6E9005A-D646-4FF6-AE05-22225019815DQ24337897-72D16693-5333-46F5-A65A-69214347CA54Q26828952-3E6A3DFB-646D-48DC-900B-34A6B86F94DFQ26862947-67C81E0E-BF14-48A3-86EA-396FF254502CQ26998711-52EC3A48-009D-4FC3-A1FB-F692C7F5D1C5Q27010562-01B8034E-3AC8-4DDC-9537-38C6B01104FEQ27013358-F93335F0-6089-42E0-8F56-75CD22F3DA3CQ27022250-7A8340C9-EFB4-4840-A241-DF2F6BBC6EC3Q28078911-279D4F74-4E28-4827-B15F-60A87C4B9695Q28084679-20A07F41-7AAE-46BD-955C-F948EBB93CAFQ28087227-A4F44D10-AEE3-42B9-9D18-DB21EAE3EB1BQ28087307-F02E0A3C-5836-47FF-8604-C376661FCA5BQ28115608-C581CA99-9D4B-4D4A-86A0-2453B1248D38Q28538218-ADBD5100-D530-4D93-9CF4-55E437AE8B15Q30362279-68D9A49E-FEC4-4A73-9644-72B43B9621D7Q30566060-10B0C7B5-0D1D-4BE2-9174-4D8118C57219Q30584224-DC85CB78-B321-4BE2-9E77-0647F5BCDBB3Q33611375-76A4DDAF-00AA-4053-A4A8-6AD7F46F13F2Q33779529-B8361425-5AE8-41D2-AC58-E277602487CAQ33893517-4D671217-F342-4A48-A41E-39C722B2D4D5Q33902831-55EB106A-D49B-4EDA-A5B3-7295E935BEC6Q33917973-E541F611-DEFB-4CC2-9653-74D71B679B57Q34057772-75CA683A-F2FD-478B-8F5E-D8D28A098EE2Q34222038-B746CA44-C760-438D-8320-E342F6DDB6E3Q34419556-EC8659CE-DC47-4463-A832-896E3BC90657Q34426426-8FDBA4B2-6680-4801-8C85-5C4BC5C7584EQ34520026-CC388812-308A-442C-A6AB-F5A4CFFB5277Q34636867-8602DF53-C047-4E5B-A93F-3567E750E816Q34795980-ED9FB994-8714-4F38-B62E-FA45C5231492Q34976606-FD6BBDC8-1996-4C56-98B2-D550800F9291Q35064876-3E097A00-C537-4CA0-99F8-B86877D9E022Q35147583-EB709DEE-164C-453A-BCC5-BA51BA8350BDQ35462598-207317D6-F6B0-4B88-8DB3-AFECFE223979Q35510477-9930C81D-9A10-4610-BA54-8C446BC9C5D8Q35648903-C31DC3FC-C8D6-4F74-BB45-5F8E176A9C4FQ35671268-467B9874-912B-4F77-95AB-0FAC54684450Q35833796-67828ADB-90AD-4165-BAEC-097C5605409FQ35833831-30ACDC98-9009-4A82-8277-BE2BC7459031Q35888470-09D3E12B-4C60-4F5A-B5EA-7A4BE09C0147Q35890262-7DD1F52C-FF6B-4C17-BB6F-4468E921A8ED
P2860
Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency.
@ast
Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency.
@en
type
label
Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency.
@ast
Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency.
@en
prefLabel
Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency.
@ast
Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency.
@en
P2860
P50
P356
P1476
Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency.
@en
P2860
P304
P356
10.1128/CMR.00001-11
P407
P577
2011-07-01T00:00:00Z